BeatO: Revolutionizing Diabetes Management in India
Unveiling BeatO: An Innovative Diabetes Management Platform
Founded in 2015 by Gautam Chopra and Yash Seghal, both of whom have diabetes, BeatO sought to make diabetes management more accessible and affordable for people across India. This innovative platform has since gained the trust of over three million users, a testament to the founders’ dedication and hard work.
A Landmark Study Affirms BeatO’s Efficacy
In their quest to improve the lives of people with diabetes, BeatO embarked on a significant study to evaluate the effectiveness of their comprehensive diabetes care program. The study involved over 700 individuals and was published in the esteemed medical journal, Diabetes, affiliated with the American Diabetes Association® (ADA) in June 2023. The study revealed a remarkable reduction of 2.16% in HbA1c levels, a measure of average blood glucose over three months. This global first underscores the efficacy of BeatO’s program in diabetes management.
BeatO’s Reach: Beyond Borders and Gender
BeatO’s influence extends far beyond India, earning it a feature on international news broadcasts for its efforts. The company has played a crucial role in extending diabetes care to underprivileged Tier 3 and 4 cities in India, providing a lifeline to individuals living with diabetes in these regions. Its user base has seen significant growth in tier 4 towns, home to many underserved populations.
Additionally, BeatO has played a key role in empowering women across India to take control of their health. The platform has witnessed a 20-fold increase in female users, demonstrating the company’s commitment to inclusivity and equal access to healthcare.
Recognition of BeatO’s Contribution to Healthcare
In 2021, in recognition of their work in democratizing healthcare and ensuring its accessibility and affordability, BeatO received the National Startup Award in the Healthcare category from the Prime Minister. This prestigious honor acknowledges BeatO’s significant contributions to the healthcare sector and its commitment to improving diabetes care in India.
Future Directions: Scaling Up and Expanding Reach
BeatO recently raised 33 million in its Series B round of funding, led by impact investor Lightrock India. The funding round also saw participation from existing investors, including healthcare-focused investor HealthQuad and ecommerce giant Flipkart. The fresh capital infusion will be utilized to expand BeatO’s diabetes care programs across the country, strengthen the leadership team, and enhance BeatO’s product and technology.
With its ambitious mission to redefine diabetes care in India, BeatO aspires to serve over 10 million patients by 2025. The platform continues to enter strategic partnerships with major players in the insurance and pharmaceutical sectors to drive large-scale impact across the country.
Conclusion: A Beacon of Hope for Diabetes Management
The story of BeatO is one of determination and commitment to making diabetes management more accessible and affordable. With over three million users and growing, BeatO continues to have a significant impact on diabetes care in India and around the world. By harnessing the power of digital technology, BeatO is setting new standards for how diabetes care is delivered, offering hope and improved health outcomes for millions of people living with diabetes.
Subscribe to BNN Breaking
Sign up for our daily newsletter covering global breaking news around the world.